Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.3K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.3K
Anatomy of the Intestines01:23

Anatomy of the Intestines

89.0K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
89.0K
Inflammation01:38

Inflammation

63.2K
Overview
63.2K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

1.8K
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.8K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

867
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
867

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global advances in health artificial intelligence: a workforce imperative.

Lancet (London, England)·2026
Same author

The Alberta Quality Assessment Tool: Risk of Bias (AQAT:RoB) for the Evaluation of Medical Large Language Model Question-Answer Studies: Development and Pilot Validation.

Journal of medical Internet research·2026
Same author

The Alberta Risk of Bias Assessment Tool (AQAT:RoB) for the Evaluation of Medical Large Language Model Question-Answer Studies: Development and Pilot Validation.

Journal of medical Internet research·2026
Same author

Comparing the accuracy of computed tomography enterography to balloon-assisted enteroscopy in the evaluation of small bowel Crohn's disease.

Journal of the Canadian Association of Gastroenterology·2026
Same author

Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): artificial intelligence in IBD surgery-opportunities and limitations.

Journal of Crohn's & colitis·2025
Same author

Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): artificial intelligence in IBD: regulatory and methodological considerations.

Journal of Crohn's & colitis·2025
Same journal

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

["Not everything that looks like a tumor..." - Pulmonary tularemia with hilar lymphadenopathy].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Emergency management of sickle cell disease].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Hereditary dehydrated stomatocytosis (= hereditary xerocytosis) - Interesting hummingbird or clinically relevant diagnosis?]

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Diagnosis of Congenital Hemolytic Anemias in Adults].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[46-year-old female patient with right upper abdominal pain].

Deutsche medizinische Wochenschrift (1946)·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.4K

[Microbiome and Gut Inflammation].

Daniel M Autenrieth, Daniel C Baumgart

    Deutsche Medizinische Wochenschrift (1946)
    |February 25, 2017
    PubMed
    Summary
    This summary is machine-generated.

    The gut microbiome is crucial for host health, with alterations linked to infectious and inflammatory bowel diseases. Current research explores modulating the gut microbiota for therapeutic benefits in these conditions.

    More Related Videos

    An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions
    05:27

    An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions

    Published on: June 30, 2021

    5.2K
    Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
    07:34

    Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

    Published on: December 16, 2021

    3.3K

    Related Experiment Videos

    Last Updated: Mar 7, 2026

    Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
    11:22

    Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

    Published on: October 15, 2019

    31.4K
    An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions
    05:27

    An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions

    Published on: June 30, 2021

    5.2K
    Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
    07:34

    Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

    Published on: December 16, 2021

    3.3K

    Area of Science:

    • Microbiology
    • Gastroenterology
    • Immunology

    Background:

    • The gut microbiome, comprising trillions of microorganisms, significantly influences host health.
    • Dysbiosis, or imbalance in gut microbiota, is associated with various diseases, including Clostridium difficile infection and inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis.

    Purpose of the Study:

    • To provide an update on recent advancements in understanding the gut microbiome's role in infectious and inflammatory bowel diseases.
    • To discuss the clinical implications of targeting the gut microbiota for therapeutic interventions.

    Main Methods:

    • Literature review of current research on gut microbiome composition and function.
    • Analysis of studies investigating the link between microbiota alterations and disease pathogenesis.
    • Evaluation of therapeutic strategies aimed at modulating the gut microbiome.

    Main Results:

    • Growing evidence confirms the critical role of the gut microbiota in maintaining host homeostasis.
    • Specific microbial profiles are associated with increased susceptibility or severity of infectious and inflammatory bowel diseases.
    • Emerging therapies focus on microbiome modulation, such as fecal microbiota transplantation and probiotics.

    Conclusions:

    • The gut microbiome is a key factor in the pathogenesis and progression of infectious and inflammatory bowel diseases.
    • Targeting the gut microbiota holds significant therapeutic potential for managing these conditions.
    • Further research is needed to fully elucidate mechanisms and optimize microbiome-based interventions.